Epitopea
ID: 12855583Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.
4
Funding Rounds
$58.3m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company Epitopea has raised a total of $58.26m in funding over 4 rounds.
Key Insights:
- Epitopea Seed Round, October 2024: $31m
- Epitopea Grant Fund, September 2024: $658k
- Epitopea Seed round, April 2022: $13.6m
- Epitopea April 2022 Seed Funding Round: $13m
Industries
Epitopea is active in the following industries: